Janssen Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 1440 Olympic Drive, Athens, Georgia (GA) 30601, United States (USA)
- Operations here
- analysisapi manufacturepack
- FDA identifiers
- FEI 1033845 · DUNS 080236951
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-01-24
- NAIDrug Quality Assurance2017-07-14
- NAIDrug Quality Assurance2014-02-20
- NAIDrug Quality Assurance2011-02-18
- NAIDrug Quality Assurance2009-03-27
Drugs this plant is listed as making
4 distinct drugs across 21 products name this site in their FDA label.
- Methylphenidate Hydrochloridein shortageAurolife Pharma, LLC
- tapentadol hydrochlorideCollegium Pharmaceutical, Inc.
- topiramateJanssen Pharmaceuticals, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.